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Various strategies are explored for continuous bioprocessing for manufacturing of recombinant proteins and 
monoclonal antibodies: 1. continuous perfusion culture plus batch product capture; 2. continuous perfusion 
culture plus semi-continuous product capture; 3. continuous perfusion culture plus continuous product capture 
(Figure 1). Our main focus has been on the several initial unit operations: high cell concentration perfusion cell 
cultures and early product capture steps, in order to realize its potentials of being flexible, improving product 
quality and lowering costs. These initial unit operations require large volumes and represent the most important 
part of this processing platform, where we can deliver the largest benefits.  
 
Figure 1 – Strategies for Continuous Bioprocessing 
 
This presentation will focus on two case studies to illustrate these strategies. The  first case study focuses on 
direct scale-up of an ATF (Alternating Tangential Flow) based high cell concentration  perfusion culture, from 2L 
scale coupled with ATF2 to large single use bioreactors of 150-1000L scale coupled with ATF6 or ATF10. 
Appropriate considerations of agitation and aeration rates, ATF operation parameters as well as bioreactor 
processing conditions resulted in successful scale-up of more than 100 folds, with highly consistent process 
performance, productivity and quality of directly captured products. 
 
Figure 2 – Consistent Performance between Scale-Up and Scale-Down Models 
The second case study involves development of high cell concentration and volumetric productivity perfusion 
cultures and continuous direct product capture. We will discuss our efforts towards intensified cell culture 
processes by culture parameter and media optimization, and a continuous direct product capture steps using 
multiple column chromatography systems. Challenges in connecting these two continuous unit operations will 
be discussed as well.  
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Pv = 2.5 g/L-day 
Qp = 25 pg/cell-day
 
